Angiopoietin-related growth factor antagonizes obesity and insulin resistance
Yuichi Oike(Kumamoto University), Toshio Suda(Chinese Academy of Sciences), Juro Sakai(Tohoku University), Masaki Akao(University of Helsinki), Motohiro Takeya(Kumamoto University), Naomi Nakagata(Kumamoto University), Toshimasa Yamauchi(The University of Tokyo), Hiromitsu Maekawa(University of Helsinki), Takashi Kadowaki(Toranomon Hospital), Yoshiaki Kubota(Keio University), Kunio Yasunaga(Astellas Pharma (China)), Yoshihiro Ogawa(Kyushu University), Keishi Miyata(Kumamoto University), Haruhiko Koseki(RIKEN Center for Integrative Medical Sciences), Yasuhiro Ito(Kuma Hospital), Shun-ichiro Matsumoto(Astellas Pharma (China)), Takashi Urano(University of Helsinki), Takeshi Miyamoto(Kumamoto Health Science University), Yoshishige Kimura(University of Helsinki), Tohru Morisada(Keio University)
Cited by 219
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Adiponectin and Adiponectin Receptors
|Endocrine Reviews|2005|2.6k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k